文献速递心力衰竭与心肌病

射血分数保留的心力衰竭中伴有毛细血管前成分的肺动脉高压

Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.
PubMed 文献 · Heart · 2023-03-27

基于PURSUIT-HFpEF注册研究,219例急性心衰住院的HFpEF患者在初始心衰治疗后行右心导管检查。按2015年定义,27%存在PH,其中毛细血管前成分占7%;2018年定义使毛细血管前PH频率翻倍(6%)。伴毛细血管前成分的PH与不良临床结局相关,特征为左心室尺寸小和高E/e'。

要点

  • HFpEF患者心衰治疗后仍可检出毛细血管前成分PH,2015年定义下占7%。
  • 2018年定义使毛细血管前PH检出频率翻倍(6%)。
  • 伴毛细血管前成分PH者左心室尺寸小、E/e'高,且临床结局差。

核心结论

  • 初始心衰治疗后,7%的HFpEF住院患者存在2015年定义的伴毛细血管前成分的PH。
  • 左心室超声参数有助于伴毛细血管前成分PH的HFpEF患者风险分层。

研究设计与样本

  • 来自PURSUIT-HFpEF前瞻性多中心观察性注册研究。
  • 219例急性心衰住院的HFpEF患者,在初始心衰治疗后行右心导管检查。
  • 按2015和2018年PH定义分为非PH、Ipc-PH、毛细血管前PH和Cpc-PH四组。

主要发现

  • 2015年定义下,心衰治疗后PH患病率为27%(Ipc-PH 20%,毛细血管前PH 3%,Cpc-PH 4%)。
  • 2018年定义使毛细血管前PH频率翻倍(6%)。
  • 2015年定义的伴毛细血管前成分PH与不良临床结局相关,特征为左心室尺寸小和高E/e'。

关键数值与推荐

  • 2015年定义:伴毛细血管前成分PH占7%(毛细血管前PH 3%+Cpc-PH 4%)。
  • 2018年定义:毛细血管前PH频率为6%。

临床怎么用

  • HFpEF患者心衰治疗后应评估是否存在毛细血管前成分PH。
  • 左心室超声参数(左心室尺寸小、高E/e')可用于风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Heart failure with preserved ejection fraction (HFpEF) is often complicated by pulmonary hypertension (PH), which is mainly characterised by postcapillary PH and occasionally accompanied by a precapillary component of PH. Haemodynamic changes in worsening heart failure (HF) can modify the characteristics of PH. However, the clinical features of PH after HF treatment in HFpEF remain unclear. We investigated the prevalence and clinical significance of the precapillary component of PH after HF treatment in HFpEF, using data from the Prospective Multicentre Observational Study of Patients with HFpEF (PURSUIT-HFpEF). METHODS: From the PURSUIT-HFpEF registry, 219 patients hospitalised with acute HF who underwent right heart catheterisation after initial HF treatment were divided into four groups according to the 2015 and 2018 PH definitions: non-PH, isolated postcapillary pulmonary hypertension (Ipc-PH), precapillary PH and combined postcapillary and precapillary pulmonary hypertension (Cpc-PH). The latter two were combined as PH with the precapillary component. RESULTS: Using the 2015 definition, we found that the prevalence of PH after HF treatment was 27% (Ipc-PH: 20%, precapillary PH: 3%, Cpc-PH: 4%). Applying the 2018 definition resulted in a doubled frequency of precapillary PH (6%). PH with a precapillary component according to the 2015 definition was associated with poor clinical outcomes and characterised by small left ventricular dimension and high early diastolic mitral inflow velocity/early diastolic mitral annular tissue velocity. CONCLUSION: After initial HF treatment, 7% of hospitalised patients with HFpEF had precapillary component of PH according to the 2015 definition. Echocardiographic parameters of the left ventricle can contribute to the risk stratification of patients with HFpEF with a precapillary component of PH.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Sera, Ohtani, Tamaki, et al. Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction. Heart. 2023. PMID: 36543519. doi:10.1136/heartjnl-2022-321565

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。